U100 Lasers & Energy Devices in the Treatment of Acne
DESCRIPTION
Acne vulgaris is the most common skin disorder in Dermatology. Medical therapy is considered first-line in the treatment of all forms of acne, including inflammatory, comedonal and nodulocystic types. Recently, new technology has been developed to address acne. This session will review the published literature on the various lasers and energy devices used in the treatment of acne vulgaris, along with an algorithm that incorporates medical therapies. Safety protocols will be reviewed, including the use of these devices in diverse racial skin types.
LEARNING OBJECTIVES
Discuss the various lasers and energy devices that are available for the treatment of acne.
Choose the appropriate laser or energy device for acne patients with diverse skin types.
Describe an algorithm that incorporates lasers/energy devices with medical therapies for acne patients.
SCHEDULE
4:30 PM
Laser Physics: How I Use New Laser Technology to Treat Acne Patients
4:45 PM
Acne Lasers in Darker Skin Types: How I Avoid Complications in Patients with Acne and Post-inflammatory Hyperpigmentation
Valerie D. Callender, MD, FAAD
5:00 PM
Lasers for Acne Scars: How I Address Acne Scars in Patients with Diverse Skin Types
Girish S. Munavalli, MD, MHS, FAAD
5:15 PM
Questions & Answers
DIRECTOR
Valerie D. Callender, MD, FAAD
SPEAKER
Girish S. Munavalli, MD, MHS, FAAD
HANDOUTS
DISCLOSURES
Valerie D. Callender, MD, FAAD
Aerolase – Advisory Board(Stock Options), Speaker/Faculty Education(Honoraria); Altree – Stockholder Private Company(Stock Options); Arcutis Biotherapeutics – Speaker(Honoraria); Beiersdorf, Inc. – Speaker(Honoraria); Callender Center for Clinical Research – Founder(No Compensation Received); Eli Lilly – Speaker/Faculty Education(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Elsevier Inc. – Independent Contractor(Honoraria); Incyte – Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Consultant(Honoraria), Investigator(Honoraria); La Roche-Posay - L'Oreal Group – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Prollenium Medical Technologies – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals Inc – Investigator(Grants/Research Funding); Restore Biologics – Advisory Board(Honoraria); Sinclair Pharma – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Speaker(Honoraria); symatese – Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Grants/Research Funding); Unilever – Advisory Board(Honoraria); UpToDate – Other(Patent royalties or other compensation for Intellectual Property Rights); Veradermics – Advisory Board(Honoraria); VeraDermics Inc. – Investigator(Grants/Research Funding); WoltersKluwer Health – Independent Contractor(Patent royalties or other compensation for Intellectual Property Rights);
Girish S. Munavalli, MD, MHS, FAAD
AbbVie – Investigator(Grants/Research Funding); Benev – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Honoraria); Lumenis – Investigator(Equipment); Sofwave – Investigator(Stock Options);